Plastic Syringe Market Soars: Envisioning a Robust CAGR of 5.3% by 2033 | FMI

Anticipated to reach a notable US$ 6.1 billion by 2033, the disposable syringe market is positioned for robust growth, projecting a steady Compound Annual Growth Rate (CAGR) of 5.3% from 2023 to 2033. The surge in disease incidence and the escalating demand for disposable syringes within the healthcare sector are key drivers propelling the growth of the plastic syringe market. With the market size expected to hit US$ 3.6 billion by 2023, the disposable syringe industry underscores its vital role in meeting the evolving healthcare needs, ensuring safety, and contributing significantly to the global landscape of medical consumables.

Highlighting a shift toward sustainability, the single-use plastic needle syringe market is increasingly emphasizing recyclable and biodegradable materials, addressing environmental concerns and aligning with eco-friendly practices. In the realm of personalized medicine, syringe technology is poised to harmonize with evolving trends, offering customized drug delivery solutions that cater to individual patient needs and treatment requirements. The future of syringe technology is anticipated to witness transformative advancements with the integration of automation and artificial intelligence, aiming to enhance the precision and efficiency of both syringe manufacturing processes and drug administration practices. This intersection of technology and healthcare holds promise for elevating the standards of accuracy and performance in the syringe industry.

Asia Pacific currently dominates the plastic syringe market. The region’s impressive economic growth and growing healthcare infrastructure provide a favorable environment for market expansion. Notably, the sheer size of the population, particularly in populous countries like China and India, drives a steady and significant demand for medical services, which in turn causes the adoption of plastic syringe.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-9211

Key Takeaways 

• The polypropylene segment in the material category to grab a share of 35.3% from 2023 to 2033.
• In the application category, the insulin syringe segment to acquire a market share of 37.1% between 2023 and 2033.
• The United States plastic syringe market to exhibit a CAGR of 2.8% by 2023.
• Canada plastic syringe market syringe market is to exhibit a CAGR of 3.9% by 2023.
• Germany syringe and needle market to register a CAGR of 2.3% by 2023.
• Japan plastic syringe market syringe market to record a CAGR of 3.2% by 2023.
• Thailand syringe and needle market to develop at a CAGR of 5.5% by 2023.
• China plastic syringe market is to accelerate at a CAGR of 5.9% through 2033.
• South Korea syringe and needle market is to experience growth at a CAGR of 4.6% from 2023 to 2033.
• The United Kingdom plastic syringe market syringe market to evolve at a CAGR of 4.4% through 2033.

“The plastic syringe market is augmenting steadily due to rising demand in the healthcare and pharmaceutical sectors. Market growth for plastic syringes is aided by cost-effectiveness, safety, and ease of use. The plastic syringe market may blossom, with new materials and designs to strengthen its appeal to healthcare professionals and manufacturers.” Comments an analyst at FMI.

Competitive Landscape

The plastic syringe manufacturers are to begin mass production, and companies active in the market are ceasing their efforts to get their products approved. Preventing accidental needle stick injuries in healthcare settings is a critical issue that disposable syringe manufacturers are concerned with.

Key manufacturers are enhancing their research and development capacities to introduce secure medical procedures, which may accelerate market growth in plastic syringe.

Key Plastic Syringe Manufacturers

• Becton, Dickinson and Company
• Braun Medical Inc.
• Gerresheimer AG
• Terumo Corporation
• Smiths Medical
• Hindustan Syringes and Medical Devices Limited
• NIPRO Corporation
• Schott AG
• CODAN Medizinische Geräte GmbH and Co KG
• CHEMI S.p.A
• Others

Noteworthy Developments

• To support the KinetiX syringe, a ready-to-administer platform comprised of plastic, Genixus planned to construct a 30,000-square-foot manufacturing facility in North Carolina, the United States, in March 2023. The facility would be supplied with automated production equipment.
• In May 2022, SCHOTT Pharma officially opened its new production plant in Müllheim, Germany, for pre-fillable syringes made of premium polymer.
• Terumo Pharmaceutical Solutions unveiled a ready-to-fill polymer syringe with a greater volume for complex biotech medications in October 2022.

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/9211